Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Charles River Laboratories International, Inc. Common Stock (NY: CRL )

166.93 -3.66 (-2.15%)
Official Closing Price Updated: 4:10 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,129,956
Open 169.36
Bid (Size) 150.11 (4)
Ask (Size) 184.00 (2)
Prev. Close 170.59
Today's Range 166.85 - 172.25
52wk Range 150.79 - 274.76
Shares Outstanding 50,396,622
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Unpacking Q4 Earnings: UFP Technologies (NASDAQ:UFPT) In The Context Of Other Drug Development Inputs & Services Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at drug development inputs & services stocks,... 
Via StockStory
Charles River Laboratories to Present at Barclays Global Healthcare Conference
From Charles River Laboratories International, Inc.
Via Business Wire

Performance

YTD
-8.60%
-8.60%
1 Month
+4.40%
+4.40%
3 Month
-13.75%
-13.75%
6 Month
-13.77%
-13.77%
1 Year
-36.80%
-36.80%

More News

Read More
Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4
Via StockStory
Charles River Announces Agreement with Singapore General Hospital
From Charles River Laboratories International, Inc.
Via Business Wire
Earnings Scheduled For February 19, 2025
Via Benzinga
Analyst Expectations For Charles River's Future
Via Benzinga
Uncover the latest developments among S&P500 stocks in today's session.
Via Chartmill
Exploring the top movers within the S&P500 index during today's session.
Via Chartmill
UFP Technologies (UFPT) Reports Q4: Everything You Need To Know Ahead Of Earnings
Via StockStory
Analyst Sees Charles River As Preclinical Leader But Maintains Neutral Stance
Via Benzinga
What Analysts Are Saying About Charles River Stock
Via Benzinga
Which S&P500 stocks are moving on Wednesday?
Via Chartmill
In today's session, there are S&P500 stocks with remarkable trading volume.
Via Chartmill
What's going on in today's session: S&P500 movers
Via Chartmill
Earnings To Watch: Repligen (RGEN) Reports Q4 Results Tomorrow
Via StockStory
Charles River Laboratories (NYSE:CRL) Posts Better-Than-Expected Sales In Q4
Via StockStory
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance
From Charles River Laboratories International, Inc.
Via Business Wire
Earnings To Watch: Charles River Laboratories (CRL) Reports Q4 Results Tomorrow
Via StockStory
Charles River and Deciphex Extend Global Partnership to Expand Digital Pathology Offering with Exclusive Image Management Solutions
From Charles River
Via Business Wire
Uncover the latest developments among S&P500 stocks in today's session.
Via Chartmill
Gapping S&P500 stocks in Monday's session
Via Chartmill
Charles River Laboratories Schedules Fourth-Quarter 2024 Earnings and 2025 Guidance Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
This STMicroelectronics Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday
Via Benzinga
Charles River Expands Apollo™ Ecosystem, Offering Bespoke Client Experiences
From Charles River Laboratories International, Inc.
Via Business Wire
This Spotify Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.